ORDER
REPRINTS
622
Strizhak et al.
2JP–H ¼ 13.1 Hz, 1H), 7.7–7.4 (m, 3H), 7.22 (t, 1H). 3.0–2.7 (m, 4H), 2.1–
1.7 (m, 7H). Anal. Calcd. for C14H16N3O3PS [337.34]: C, 49.85; H, 4.78; N,
12.46. Found: C, 50.02; H, 4.77; N, 12.54.
Methyl-N-(4-nitrophenyl)4,5,6,7-tetrahydro-1,3-benzothiazol-2-
ylphosphinic amide (5j) was synthesized from 3a and p-nitroaniline. Yellow
crystals, m.p. 2168C (1.301 g, 77%). 1H NMR (CDCl3, d): 8.02 (d, 2H), 7.51
2
(d, JP–H ¼ 12.5 Hz, 1H), 7.15 (d, 2H), 3.0–2.6 (m, 4H), 2.2–1.7 (m, 7H).
Anal. Calcd. for C14H16N3O3PS [337.34]: C, 49.85; H, 4.78; N, 12.46. Found:
C, 49.99; H, 4.71; N, 12.51.
Methyl-N-(2-pyridinyl)4,5,6,7-tetrahydro-1,3-benzothiazol-2-ylphos-
phinic amide (5k) was synthesized from 3a and 2-aminopyridine. Pale yellow
crystals, m.p. 1468C (0.894 g, 61%). 1H NMR (CDCl3, d): 8.14 (d, 1H), 7.48
(t, 1H), 6.98 (d, 1H), 6.79 (t, 1H), 2.84 (broad s, 4H), 2.14 (d, 2JP–H ¼ 15.9 Hz,
3H), 1.84 (broad s, 4H). Anal. Calcd. for C13H16N3OPS [293.33]: C, 53.23; H,
5.50; N, 14.33. Found: C, 53.11; H, 5.60; N, 14.56.
N-(5-chloro-2-pyridinyl)methyl(4,5,6,7-tetrahydro-1,3-benzothiazol-
2-yl)phosphinic amide (5l) was synthesized from 3a and 2-amino-5-
chloropyridine. Yellow crystals, m.p. 1378C. 1H NMR (CDCl3, d): 8.05 (s, 1H),
7.38 (d, 1H), 6.92 (d, 1H), 2.83 (broad s, 4H), 2.10 (d, 2JP–H ¼ 15.9 Hz, 3H),
1.85 (broad s, 4H). Anal. Calcd. for C13H15ClN3OPS [327.77]: C, 47.64; H,
4.61; N, 12.82. Found: C, 47.39; H, 4.66; N, 12.98.
N-(2-chlorophenyl)phenyl(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)
phosphinic amide (6a) was synthesized from 3b and o-chloroaniline.
Colorless crystals, m.p. 1698C (1.381 g, 71%). 1H NMR (DMSO-D6, d): 8.0–
7.7 (m, 3H), 7.6–7.3 (m, 4H), 7.2–6.8 (m, 2H), 2.76 (broad s, 4H), 1.75 (broad
s, 4H). Anal. Calcd. for C19H18ClN2OPS [388.86]: C, 58.69; H, 4.67; N, 7.20.
Found: C, 58.81; H, 4.66; N, 7.31.
N-(4-chlorophenyl)phenyl(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)
phosphinic amide (6b) was synthesized from 3b and p-chloroaniline.
Colorless crystals, m.p. 1638C (1.498 g, 77%). 1H NMR (CDCl3, d): 8.0–7.7
(m, 2H), 7.4–7.2 (m, 3H), 6.97 (s, 4H), 6.52 (d, 2JP–H ¼ 10.0 Hz), 2.75 (broad
s, 4H), 1.77 (broad s, 4H). Anal. Calcd. for C19H18ClN2OPS [388.86]: C,
58.69; H, 4.67; N, 7.20. Found: C, 58.84; H, 4.51; N, 7.39.
N-(2,5-dichlorophenyl)phenyl(4,5,6,7-tetrahydro-1,3-benzothiazol-2-
yl)phosphinic amide (6c) was synthesized from 3b and 2,5-dichloroaniline.
Colorless crystals, m.p. 1828C (1.713 g, 81%). 1H NMR (CDCl3, d): 8.1–7.9
(m, 2H), 7.6–7.3 (m, 3H), 7.22 (d, 1H), 6.9–6.7 (m, 3H), 3.0–2.7 (m, 4H),
1.87 (broad s, 4H). Anal. Calcd. for C19H17Cl2N2OPS [423.30]: C, 53.91; H,
4.05; N, 6.62. Found: C, 54.10; H, 4.11; N, 6.66.
N-(2,6-dichlorophenyl)phenyl(4,5,6,7-tetrahydro-1,3-benzothiazol-2-
yl)phosphinic amide 6d was synthesized by non-standard procedure. A
mixture of 5 mmol of 3b and 15 mmol of 2,6-dichloroaniline was heated at